Endoscopic radiofrequency ablation therapy for the prevention of esophageal cancer in Barrett’s esophagus

References

• Lord RV, Law MG, Ward RL, Giles GG, Thomas RJ, Thursfield V. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol. 1998;13(4):356–362.
   Web of Science ®Google Scholar
• Hansson LE, Sparen P, Nyren O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer. 1993;54(3):402–407.
   Web of Science ®Google Scholar
• Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–146.
   PubMed Web of Science ®Google Scholar
• Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett’s esophagus in an Australian health region. Am J Gastroenterol. 2006;101(6):1178–1182.
   Web of Science ®Google Scholar
• Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96(5 Pt 1):1249–1256.
   Web of Science ®Google Scholar
• Alexandropoulou K, van Vlymen J, Reid F, Poullis A, Kang JY. Temporal trends of Barrett’s oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study. Eur J Gastroenterol Hepatol. 2013;25(1):15–21.
   Web of Science ®Google Scholar
• Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2013;103(13):1049–1057.
   Google Scholar
• Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375–1383.
   PubMed Web of Science ®Google Scholar
• Murray L, Watson P, Johnston B, Sloan J, Mainie IM, Gavin A. Risk of adenocarcinoma in Barrett’s oesophagus: population based study. BMJ. 2003;327(7414):534–535.
   Google Scholar
• Schouten LJ, Steevens J, Huysentruyt CJ, et al. Total cancer incidence and overall mortality are not increased among patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2011;9(9):754–761.
   Web of Science ®Google Scholar
• Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120(7):1630–1639.
   PubMed Web of Science ®Google Scholar
• Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol. 2000;95(11):3089–3096.
   Web of Science ®Google Scholar
• Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990;99(4):918–922.
   PubMed Web of Science ®Google Scholar
• Sharma VK, Jae Kim H, Das A, Wells CD, Nguyen CC, Fleischer DE. Circumferential and focal ablation of Barrett’s esophagus containing dysplasia. Am J Gastroenterol. 2009;104(2):310–317.
   PubMed Web of Science ®Google Scholar
• Kubo A, Cook MB, Shaheen NJ, et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett’s oesophagus: a pooled analysis from the international BEACON consortium. Gut. 2013;62(12):1684–1691.
   Web of Science ®Google Scholar
• Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399–1412. e7.
   PubMed Web of Science ®Google Scholar
• Cook MB, Shaheen NJ, Anderson LA, et al. Cigarette smoking increases risk of Barrett’s esophagus: an analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012;142(4):744–753.
   PubMed Web of Science ®Google Scholar
• Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005;162(11):1050–1061.
   PubMed Web of Science ®Google Scholar
• Corley DA, Kubo A, Levin TR, et al. Race, ethnicity, sex and temporal differences in Barrett’s oesophagus diagnosis: a large community-based study, 1994–2006. Gut. 2009;58(2):182–188.
   Web of Science ®Google Scholar
• Chak A, Lee T, Kinnard MF, et al. Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut. 2002;51(3):323–328.
   Web of Science ®Google Scholar
• Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut. 2008;57(2):173–180.
   Web of Science ®Google Scholar
• Basu KK, Bale R, West KP, de Caestecker JS. Persistent acid reflux and symptoms in patients with Barrett’s oesophagus on proton-pump inhibitor therapy. Eur J Gastroenterol Hepatol. 2002;14(11):1187–1192.
   Web of Science ®Google Scholar
• Whiteman DC, Appleyard M, Bahin FF, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol. 2015;30(5):804–820.
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084–1091.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):e18–e52; quiz e13.
   PubMed Web of Science ®Google Scholar
• Rubenstein JH, Sonnenberg A, Davis J, McMahon L, Inadomi JM. Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc. 2008;68(5):849–855.
   PubMed Web of Science ®Google Scholar
• Frazzoni M, Manno M, De Micheli E, Savarino V. Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors. Dig Liver Dis. 2007;39(5):415–421.
   Google Scholar
• Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett’s esophagus. Am J Gastroenterol. 1997;92(4):582–585.
   PubMed Web of Science ®Google Scholar
• Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett’s oesophagus: a systematic review and meta-analysis. Gut. 2014; 63(8):1229–1237.
   PubMed Web of Science ®Google Scholar
• Rees JR, Lao-Sirieix P, Wong A, Fitzgerald RC. Treatment for Barrett’s oesophagus. Cochrane Database Syst Rev. 2010;(1):CD004060.
   Web of Science ®Google Scholar
• Attwood SE, Lundell L, Hatlebakk JG, et al. Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3-year experience. J Gastrointest Surg. 2008;12(10):1646–1654; discussion 54–55.
   Web of Science ®Google Scholar
• Zehetner J, DeMeester SR, Ayazi S, et al. Long-term follow-up after anti-reflux surgery in patients with Barrett’s esophagus. J Gastrointest Surg. 2010;14(10):1483–1491.
   Web of Science ®Google Scholar
• Yau P, Watson DI, Devitt PG, Game PA, Jamieson GG. Laparoscopic antireflux surgery in the treatment of gastroesophageal reflux in patients with Barrett esophagus. Arch Surg. 2000;135(7):801–805.
   Google Scholar
• Wassenaar EB, Oelschlager BK. Effect of medical and surgical treatment of Barrett’s metaplasia. World J Gastroenterol. 2010;16(30):3773–3779.
   Web of Science ®Google Scholar
• Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237(3):291–298.
   PubMed Web of Science ®Google Scholar
• Ye W, Chow WH, Lagergren J, Yin L, Nyren O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology. 2001; 121(6):1286–1293.
   PubMed Web of Science ®Google Scholar
• Tran T, Spechler SJ, Richardson P, El-Serag HB. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol. 2005;100(5):1002–1008.
   Web of Science ®Google Scholar
• Lord RV. Does antireflux surgery prevent progression of Barrett’s esophagus? Minerva Chir. 2011;66(1):1–6.
   Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. Epithelial Radiofrequency Ablation for Barrett’s Oesophagus. London, UK: National Institute for Health and Clinical Excellence; 2010.
   Google Scholar
• Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett’s esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc. 1996;44(5):532–535.
   Web of Science ®Google Scholar
• Wolfsen HC. Endoluminal therapy for Barrett’s esophagus. Gastrointest Endosc Clin N Am. 2007;17(1):59–82, vi–vii.
   Google Scholar
• Gurgacz SCJ, Cameron A, Goodall S. Radiofrequency ablation for Barrett’s oesophagus with dysplasia. Assessment Report. Canberra, ACT: Commonwealth of Australia; 2010.
   Google Scholar
• Sie C, Bright T, Schoeman M, et al. Argon plasma coagulation ablation versus endoscopic surveillance of Barrett’s esophagus: late outcomes from two randomized trials. Endoscopy. 2013;45(11):859–865.
   Web of Science ®Google Scholar
• Van Laethem JL, Cremer M, Peny MO, Delhaye M, Deviere J. Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut. 1998;43(6):747–751.
   Web of Science ®Google Scholar
• Bright T, Watson DI, Tam W, et al. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett’s esophagus in patients treated with antisecretory medication. Dig Dis Sci. 2009;54(12):2606–2611.
   Web of Science ®Google Scholar
• Bright T, Watson DI, Tam W, et al. Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results. Ann Surg. 2007;246(6):1016–1020.
   Web of Science ®Google Scholar
• Ackroyd R, Tam W, Schoeman M, Devitt PG, Watson DI. Prospective randomized controlled trial of argon plasma coagulation ablation vs endoscopic surveillance of patients with Barrett’s esophagus after antireflux surgery. Gastrointest Endosc. 2004;59(1):1–7.
   Web of Science ®Google Scholar
• Aranda-Hernandez J, Cirocco M, Marcon N. Treatment of dysplasia in barrett esophagus. Clin Endosc. 2014;47(1):55–64.
   Google Scholar
• Mayne GC, Bright T, Hussey DJ, Watson DI. Ablation of Barrett’s oesophagus: towards improved outcomes for oesophageal cancer? ANZ J Surg. 2012;82(9):592–598.
   Web of Science ®Google Scholar
• Kelty CJ, Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW. Endoscopic ablation of Barrett’s oesophagus: a randomized-controlled trial of photodynamic therapy vs argon plasma coagulation. Aliment Pharmacol Ther. 2004;20(11–12):1289–1296.
   Web of Science ®Google Scholar
• Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62(4):488–498.
   PubMed Web of Science ®Google Scholar
• Wang KK. Photodynamic therapy of Barrett’s esophagus. Gastrointest Endosc Clin N Am. 2000;10(3):409–419.
   Google Scholar
• Peters JH, Watson TA. Endoscopic mucosal resection of Barrett’s esophagus and early esophageal cancer. J Gastrointest Surg. 2011;15(8):1299–1302.
   Web of Science ®Google Scholar
• Chennat J, Konda VJ, Ross AS, et al. Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma – an American single-center experience. Am J Gastroenterol. 2009;104(11):2684–2692.
   PubMed Web of Science ®Google Scholar
• Pouw RE, Seewald S, Gondrie JJ, et al. Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut. 2010;59(9):1169–1177.
   PubMed Web of Science ®Google Scholar
• Pech O, May A, Manner H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146(3):652–660. e1.
   PubMed Web of Science ®Google Scholar
• Chung A, Bourke MJ, Hourigan LF, et al. Complete Barrett’s excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture. Endoscopy. 2011;43(12):1025–1032.
   Web of Science ®Google Scholar
• Lopes CV, Hela M, Pesenti C, et al. Circumferential endoscopic resection of Barrett’s esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc. 2007;21(5):820–824.
   Web of Science ®Google Scholar
• Bennett C, Green S, Barr H, et al. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett’s oesophagus. Cochrane Database Syst Rev. 2010;(5):CD007334.
   Google Scholar
• National Institute for Health and Clinical Excellence. Thorascopically Assisted Oesophagectomy (IPG189). London, UK: National Institute for Health and Clinical Excellence; 2010.
   Google Scholar
• Le Page PA, Velu PP, Penman ID, Couper GW, Paterson-Brown S, Lamb PJ. Surgical and endoscopic management of high grade dysplasia and early oesophageal adenocarcinoma. Surgeon. Epub March 2, 2015.
   Google Scholar
• Lam YH, Bright T, Leong M, Thompson SK, Mayne G, Watson DI. Oesophagectomy is a safe option for early adenocarcinoma arising from Barrett’s oesophagus. ANZ J Surg. Epub February 23, 2015.
   Google Scholar
• Wu J, Pan YM, Wang TT, Gao DJ, Hu B. Endotherapy versus surgery for early neoplasia in Barrett’s esophagus: a meta-analysis. Gastrointest Endosc. 2014;79(2):233–241. e2.
   PubMed Web of Science ®Google Scholar
• Ertan A, Zaheer I, Correa AM, Thosani N, Blackmon SH. Photodynamic therapy vs radiofrequency ablation for Barrett’s dysplasia: efficacy, safety and cost-comparison. World J Gastroenterol. 2013;19(41):7106–7113.
   PubMed Web of Science ®Google Scholar
• van Vilsteren FG, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut. 2011;60(6):765–773.
   PubMed Web of Science ®Google Scholar
• Zemlyak AY, Pacicco T, Mahmud EM, et al. Radiofrequency ablation offers a reliable surgical modality for the treatment of Barrett’s esophagus with a minimal learning curve. Am Surg. 2012;78(7):774–778.
   Web of Science ®Google Scholar
• Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360(22):2277–2288.
   PubMed Web of Science ®Google Scholar
• Ganz RA, Overholt BF, Sharma VK, et al. Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a US Multicenter Registry. Gastrointest Endosc. 2008;68(1):35–40.
   Web of Science ®Google Scholar
• Vaccaro BJ, Gonzalez S, Poneros JM, et al. Detection of intestinal metaplasia after successful eradication of Barrett’s Esophagus with radiofrequency ablation. Dig Dis Sci. 2011;56(7):1996–2000.
   PubMed Web of Science ®Google Scholar
• Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010;8(1):23–29.
   Web of Science ®Google Scholar
• Vassiliou MC, von Renteln D, Wiener DC, Gordon SR, Rothstein RI. Treatment of ultralong-segment Barrett’s using focal and balloon-based radiofrequency ablation. Surg Endosc. 2010;24(4):786–791.
   Web of Science ®Google Scholar
• Lyday WD, Corbett FS, Kuperman DA, et al. Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010;42(4):272–278.
   Web of Science ®Google Scholar
• Phoa KN, van Vilsteren FG, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311(12):1209–1217.
   PubMed Web of Science ®Google Scholar
• Perry KA, Walker JP, Salazar M, Suzo A, Hazey JW, Melvin WS. Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center. Surg Endosc. 2014;28(3):777–782.
   Web of Science ®Google Scholar
• Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010;42(10):781–789.
   PubMed Web of Science ®Google Scholar
• Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008;40(5):370–379.
   Web of Science ®Google Scholar
• Dunbar KB, Spechler SJ. Controversies in Barrett esophagus. Mayo Clin Proc. 2014;89(7):973–984.
   Web of Science ®Google Scholar
• Gupta M, Iyer PG, Lutzke L, et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US Multicenter Consortium. Gastroenterology. 2013;145(1):79–86. e1.
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology. 2011;141(2):460–468.
   PubMed Web of Science ®Google Scholar
• Dulai PS, Pohl H, Levenick JM, Gordon SR, MacKenzie TA, Rothstein RI. Radiofrequency ablation for long- and ultralong-segment Barrett’s esophagus: a comparative long-term follow-up study. Gastrointest Endosc. 2013;77(4):534–541.
   Web of Science ®Google Scholar
• Curvers WL, ten Kate FJ, Krishnadath KK, et al. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol. 2010;105(7):1523–1530.
   PubMed Web of Science ®Google Scholar
• Duits LC, Phoa KN, Curvers WL, et al. Barrett’s oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel. Gut. 2015;64(5):700–706.
   PubMed Web of Science ®Google Scholar
• Kaneshiro DK, Post JC, Rybicki L, Rice TW, Goldblum JR. Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma. Am J Surg Pathol. 2011;35(5):697–700.
   Web of Science ®Google Scholar
• Nentwich MF, von Loga K, Reeh M, et al. Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg. 2014;18(2):242–249; discussion 249.
   Web of Science ®Google Scholar
• Bulsiewicz WJ, Kim HP, Dellon ES, et al. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett’s esophagus. Clin Gastroenterol Hepatol. 2013;11(6):636–642.
   PubMed Web of Science ®Google Scholar
• Davila ML, Hofstetter WL. Endoscopic management of Barrett’s esophagus with high-grade dysplasia and early-stage esophageal adenocarcinoma. Thorac Surg Clin. 2013;23(4):479–489.
   Web of Science ®Google Scholar
• Chabrun E, Marty M, Zerbib F. Development of esophageal adenocarcinoma on buried glands following radiofrequency ablation for Barrett’s esophagus. Endoscopy. 2012;(44 Suppl 2):E392. UCTN.
   Google Scholar
• Titi M, Overhiser A, Ulusarac O, et al. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett’s esophagus. Gastroenterology. 2012;143(3):564–566. e1.
   PubMed Web of Science ®Google Scholar
• Dunkin BJ, Martinez J, Bejarano PA, et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc. 2006;20(1):125–130.
   PubMed Web of Science ®Google Scholar
• Hage M, Siersema PD, Vissers KJ, et al. Genomic analysis of Barrett’s esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci. Int J Cancer. 2006;118(1):155–160.
   Web of Science ®Google Scholar
• Paulson TG, Xu L, Sanchez C, et al. Neosquamous epithelium does not typically arise from Barrett’s epithelium. Clin Cancer Res. 2006;12(6):1701–1706.
   Web of Science ®Google Scholar
• Lopes CV, Pereira-Lima J, Hartmann AA. p53 immunohistochemical expression in Barrett’s esophagus before and after endoscopic ablation by argon plasma coagulation. Scand J Gastroenterol. 2005;40(3):259–263.
   Web of Science ®Google Scholar
• Pouw RE, Gondrie JJ, Rygiel AM, et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett’s esophagus containing neoplasia. Am J Gastroenterol. 2009;104(6):1366–1373.
   PubMed Web of Science ®Google Scholar